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7 Summary 
Evaluation of the acute-phase-proteins haptoglobin and fibrinogen in calves 
with pneumonia 
Respiratory tract disease causes great financial losses in the cattle industry. The objective of 
this study was to evaluate the ability of the two acute–phase–proteins haptoglobin and 
fibrinogen to determine severity of inflammation, to control treatment success and to predict 
course of disease in calves with pneumonia.  
 
Calves with respiratory tract disease (n=147) and healthy calves (n=43) were examined on 
five days (day 0, 1, 2, 3, 7). The calves were 2 to 6 weeks old. Clinical parameters such as 
body temperature, respiration rate and a clinical score were determined. Blood samples to 
analyse the proteins were collected. Ultrasound was used to determine the extent of lung 
inflammation.  
After first examination the diseased calves were divided into three different treatment groups 
(group 1: florfenicol [20mg/kg, 2x in 48h], group 2: oxytetracycline [5mg/kg, 3x every 24h] 
and group 3: florfenicol [20mg/kg, 2x in 48h] and flunixin-meglumin [2,2mg/kg, 1x on first 
treatment day]). 
Fibrinogen was analysed by a coagulation method modified by Clauss (1959) and haptoglobin 
by measuring the peroxidase activity of the haemoglobin-haptoglobin-complex. 
 
The protein concentrations differed significantly (p<0,01) between diseased and healthy 
calves. On the first day the diseased calves had an average haptoglobin concentration of 0,324 
(95% C.I.: 0,266 – 0,394) mg/ml and on the second day a concentration of 0,347 (95% C.I.: 
0,291 – 0,412) mg/ml. On day seven the haptoglobin concentration declined to 0,063 (95% 
C.I.: 0,043- 0,094) mg/ml in the diseased group. The healthy calves had an average 
haptoglobin concentration of 0,061 (95% C.I.: 0,033 – 0,114) mg/ml on the first day and of 
0,042 (95% C.I.: 0,021-0,086) mg/ml on the second day. The concentration of fibrinogen was 
526,1 ± 159,6 mg/dl on first day in the diseased group and 547,6 ± 145,2 mg/dl on second 
day. On day seven the fibrinogen concentration declined to 431,1 ± 118,3 mg/dl in the 
diseased calves. The healthy calves showed an average fibrinogen concentration of 360 ± 106 
mg/dl on day one and of 368 ± 122 mg/dl on day two.  
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As expected all clinical parameters differed significantly between the diseased and healthy 
calves on day one. The clinical score was significantly higher in the diseased group than in 
the healthy group on all days. Only limited differences were found between the two groups 
with sonographic examination. 
 
There were significant correlations between haptoglobin and fibrinogen concentrations. The 
protein concentrations also correlated significantly with the clinical parameters on the 
respective days. 
 
After treatment the protein concentrations declined. Significant differences in the 
concentration of acute-phase-proteins were found between the three treatment groups on day 
seven, but they had no effect on the clinical outcome. The clinical score on the first day 
proved to be the best prognostic indicator for treatment success or for course of disease. The 
acute-phase-proteins showed only limited potential to predict the clinical outcome. 
 
Over all, the results indicate, that haptoglobin and fibrinogen concentrations in healthy calves 
are different from those in calves with inflammatory, non-treated diesease. Significant 
correlations between haptoglobin and fibrinogen and between the acute-phase-proteins and 
clinical parameters were found. 
 
Further research is required to investigate the diagnostic and prognostic value of haptoglobin 
and fibrinogen. Special interest should be set on correlation between acute-phase-proteins and 
lung lesions as well as verification of treatment effect. 
 
